Cancer Chemotherapy-induced Neutropenia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA label_change · 2025-08-18
FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)
FDA-approved a supplemental application for NEULASTA (pegfilgrastim) submitted by Amgen.